Clinical Trials Directory

Trials / Unknown

UnknownNCT02591823

Hair Fall in Patients on Low Dose Methotrexate

Observational Study of Hair Fall in Rheumatoid Arthritis Patients Treated With Low Dose Methotrexate

Status
Unknown
Phase
Study type
Observational
Enrollment
80 (estimated)
Sponsor
Columbia Asia · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Low dose methotrexate used in rheumatoid arthritis is considered very safe and has a side effect profile very different from that seen with high dose methotrexate used in oncology. Hair fall has been found to occur in high dose methotrexate but there is no data regarding the same when methotrexate is used in low dose.Thus this observational case control study is being undertaken to determine whether rheumatoid arthritis patients really need to be concerned about hair fall when on low dose methotrexate.

Conditions

Timeline

Start date
2015-10-01
Primary completion
2016-04-01
Completion
2016-05-01
First posted
2015-10-30
Last updated
2016-01-14

Locations

1 site across 1 country: India

Source: ClinicalTrials.gov record NCT02591823. Inclusion in this directory is not an endorsement.

Hair Fall in Patients on Low Dose Methotrexate (NCT02591823) · Clinical Trials Directory